Mayra Enid Rodriguez Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: H1 Hacienda La Gloria, Guayanilla, PR 00656 Phone: 787-608-3980 |
Mirta Caraballo Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: Orquidea St Segunda Extension Santa Elena 00656, B3, Guayanilla, PR 00656 Phone: 787-835-3083 |
Cynthia Cortes Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: Hc 2 Box 7927, Guayanilla, PR 00656 Phone: 787-412-8439 |
Sandra Perez Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: Barrio Quebrada Carr 127 Km 7.1, Guayanilla, PR 00656 Phone: 787-380-4396 Fax: 787-844-4130 |
Alberto Caraballo Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: F2 Calle 25, Urbanizacion Santa Maria, Guayanilla, PR 00656 Phone: 787-949-6313 Fax: 787-835-6675 |
News Archive
In a study that looked at data over a 10-year period, York University researchers, in collaboration with Children's Hospital of Eastern Ontario and the Institute for Clinical Evaluative Sciences, found that more than two-thirds of youth and children with an acute concussion do not seek medical follow-up or clearance as recommended by current international concussion guidelines.
DST Health Solutions, LLC, a leading provider of technology solutions and services to greater than 250 health plans, integrated delivery systems, and health care providers representing greater than 20 million members, today announced the execution of a contract to provide administration operations, care management, and business analytics to Thrive Health Plans, Inc., a Washington D.C.-based managed care organization which operates under the name Trusted Health Plan.
"The Grand Challenges in Global Health initiative, backed by the Bill & Melinda Gates Foundation, launched the 'Next Generation of Condom' challenge this month," NBC News Los Angeles reports (Ebright, 3/23).
Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.
› Verified 1 days ago